The current study focused on how GLP-1s and these genetic variants influence blood sugar levels
The Phase 3 SURMOUNT trials, which enrolled over 6,000 participants, did not exclude patients taking antioxidant supplements (including glutathione precursors like N-acetylcysteine)
Tirzepatide may be appropriate for patients with type 2 diabetes seeking maximum HbA1c reduction, those with obesity-related metabolic syndrome, or individuals who have plateaued on semaglutide
Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised phase 2 trial
Blue Cross and Blue Shield of Oklahoma does not dictate or direct providers in the practice of medicine, nor the exercise of medical judgment, nor making health care service treatment decisions
What percentage of GLP-1 users are currently taking small doses